Trevor joined Charnwood Molecular as Chief Financial Officer in March 2020. Prior to then, Trevor has focused his career in the Healthcare and Life Sciences sector, holding a number of financial leadership roles in businesses covering a range from high street healthcare, hospital operations, medical device manufacture and distribution, and laboratory services for clinical life science and medical research.

Qualifications.

Having studied Chemistry at University of Leicester and gained a PhD with University of Nottingham in the study of organometallic reactions in low temperature polymer matrices, Trevor shifted focus towards financial management and qualified as a Chartered Accountant with Ernst & Young.

Specialisms.

Before joining Charnwood, he served as Finance Director at Source BioScience, a PE backed Life Sciences group offering diverse products and services to academia, Big Pharma and the NHS, and prior to that as Director of Finance with Fresenius Medical Care, a global healthcare corporation. He is focused on supporting Charnwood’s lab teams through maintaining a solid corporate infrastructure as the business grows.